Sara-Bay Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$473K Buy
1,450
+450
+45% +$147K 0.17% 49
2025
Q1
$268K Buy
1,000
+15
+2% +$4.03K 0.12% 69
2024
Q4
$232K Buy
985
+235
+31% +$55.5K 0.09% 82
2024
Q3
$206K Buy
+750
New +$206K 0.07% 81